White label ELPA - ClinicalTrials.eu

Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
Study on the Safety and Effectiveness of Tecaginlimab and Pembrolizumab with Radiotherapy for Patients with Metastatic Solid Tumors

Not recruiting

1 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Tecaginlimab
- Pembrolizumab
Study on Ceralasertib and Durvalumab for Patients with Advanced Melanoma Resistant to PD-(L)1 Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
Study on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients

Not recruiting

3 1
Investigated diseases:
- Myotonic dystrophy
Investigated drugs:
- Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
+1
Study on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors

Not recruiting

1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Necvax-Neo1
Study on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Not recruiting

1 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Gemtuzumab Ozogamicin
- Gilteritinib
Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

Not recruiting

3 1 1 1
Investigated diseases:
- Spinal muscular atrophy
Investigated drugs:
- Onasemnogene Abeparvovec
Study of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation

Not recruiting

3 1
Investigated drugs:
- Tofersen
Study on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases

Not recruiting

2 1 1 1
Investigated diseases:
- Cutaneous sarcoidosis
Investigated drugs:
- Sirolimus

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies